ORALAIR TABLET

Krajina: Kanada

Jazyk: angličtina

Zdroj: Health Canada

Aktívna zložka:

GRASS POLLEN ALLERGEN EXTRACT

Dostupné z:

STALLERGENES CANADA INC

ATC kód:

V01AA02

INN (Medzinárodný Name):

GRASS POLLEN

Dávkovanie:

100UNIT

Forma lieku:

TABLET

Zloženie:

GRASS POLLEN ALLERGEN EXTRACT 100UNIT

Spôsob podávania:

SUBLINGUAL

Počet v balení:

3

Typ predpisu:

Prescription

Terapeutické oblasti:

ALLERGENIC EXTRACTS

Prehľad produktov:

Active ingredient group (AIG) number: 0153132001; AHFS:

Stav Autorizácia:

APPROVED

Dátum Autorizácia:

2015-04-01

Súhrn charakteristických

_ _
_Page 1 of 39_
PRODUCT MONOGRAPH
PR
ORALAIR
Grass Pollen Allergen Extract
100 IR and 300 IR Sublingual Tablets
Allergenic Substance
Stallergenes Canada Inc.
1215 North Service Road West, Suite B
Oakville, ON
L6M 2W2
Canada
Date of Preparation:
September 6, 2016
APPROVAL DATE:
NOVEMBER 18, 2016
SUBMISSION CONTROL NO: 192653
_ _
_Page 2 of 39_
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
.........................................................3
SUMMARY PRODUCT INFORMATION
........................................................................3
INDICATIONS AND CLINICAL USE
..............................................................................4
CONTRAINDICATIONS
...................................................................................................4
WARNINGS AND PRECAUTIONS
..................................................................................5
ADVERSE REACTIONS
....................................................................................................7
DRUG INTERACTIONS
.................................................................................................19
DOSAGE AND
ADMINISTRATION..............................................................................20
OVERDOSAGE
................................................................................................................21
ACTION AND CLINICAL PHARMACOLOGY
............................................................22
STORAGE AND STABILITY
..........................................................................................23
SPECIAL HANDLING INSTRUCTIONS
.......................................................................23
DOSAGE FORMS, COMPOSITION AND PACKAGING
.............................................23
PART II: SCIENTIFIC INFORMATION
...............................................................................24
PHARMACEUTICAL INFORMATION
..........................................................................24
CLINICAL TRIALS
.....................................